These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 304193)
1. Theoretical and therapeutic potential of indolamine precursors in affective disorders. Wirz-Justice A Neuropsychobiology; 1977; 3(4):199-233. PubMed ID: 304193 [TBL] [Abstract][Full Text] [Related]
2. Use of neurotransmitter precursors for treatment of depression. Meyers S Altern Med Rev; 2000 Feb; 5(1):64-71. PubMed ID: 10696120 [TBL] [Abstract][Full Text] [Related]
3. Tyrosine for the treatment of depression. Gelenberg AJ; Gibson CJ Nutr Health; 1984; 3(3):163-73. PubMed ID: 6443584 [TBL] [Abstract][Full Text] [Related]
4. [Hypothetical concept: the physiopathological entity of monoaminergic psychoses]. Tissot R Encephale; 1975; 1(4):289-339. PubMed ID: 1082812 [TBL] [Abstract][Full Text] [Related]
5. [Metabolic changes in aromatic amino acids and monoamines in infantile autism and development of new treatment related to the finding]. Naruse H; Hayashi T; Takesada M; Nakane A; Yamazaki K No To Hattatsu; 1989 Mar; 21(2):181-9. PubMed ID: 2653386 [TBL] [Abstract][Full Text] [Related]
6. Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part 1: Implications of reproducible mood elevation. Pühringer W; Wirz-Justice A; Graw P; Lacoste V; Gastpar M Pharmakopsychiatr Neuropsychopharmakol; 1976 Nov; 9(6):260-8. PubMed ID: 1087731 [TBL] [Abstract][Full Text] [Related]
7. [The influence of 1-DOPA on emotional responses and serotonin metabolism in the rat brain]. Allikmets LKh; Zharkovskiĭ AM Biull Eksp Biol Med; 1976 Feb; 81(2):134-7. PubMed ID: 1084170 [TBL] [Abstract][Full Text] [Related]
12. Integrated theory to unify status among schizophrenia and manic depressive illness. Fukuda K Med Hypotheses; 2015 Oct; 85(4):506-11. PubMed ID: 26141636 [TBL] [Abstract][Full Text] [Related]
13. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression. Amamoto T; Sarai K Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369 [No Abstract] [Full Text] [Related]
14. Monoamine precursors in the treatment of depression. Carroll BJ Clin Pharmacol Ther; 1971; 12(5):743-61. PubMed ID: 4936139 [No Abstract] [Full Text] [Related]
15. [Changes in the hypothalamo-pituitary-adrenal axis and the metabolism of serotonin in affective disorders. Therapeutic use of serotonin precursors (review)]. Pérez de los Cobos Peris J Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(3):147-274. PubMed ID: 3526823 [No Abstract] [Full Text] [Related]
17. Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part III: Neuroendocrinological and biochemical changes. Wirz-Justice A; Pühringer W; Lacoste V; Graw P; Gastpar M Pharmakopsychiatr Neuropsychopharmakol; 1976 Nov; 9(6):277-88. PubMed ID: 1087733 [TBL] [Abstract][Full Text] [Related]
18. Mood effects of the amino acids tryptophan and tyrosine: 'Food for Thought' III. Parker G; Brotchie H Acta Psychiatr Scand; 2011 Dec; 124(6):417-26. PubMed ID: 21488845 [TBL] [Abstract][Full Text] [Related]
19. The common pathophysiology of monaminergic psychoses: a new hypothesis. Tissot R Neuropsychobiology; 1975; 1(4):243-60. PubMed ID: 775359 [TBL] [Abstract][Full Text] [Related]